Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Krajcovicova

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Crohn'S & Colitis|June 6, 2015
Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much?Tibor Hlavaty, Anna Krajcovicova, Juraj Payer
European Journal of Gastroenterology & Hepatology|February 11, 2014
Delayed hypersensitivity reaction after initial dose of infliximab: a case reportAnna Krajcovicova, Tibor Hlavaty, Zuzana Zelinkova, et al.
World Journal of Gastroenterology|November 18, 2014
Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseasesTibor Hlavaty, Anna Krajcovicova, Tomas Koller, et al.
Acta Clinica Belgica|August 24, 2018
Biologic treatment in comparison to methotrexate has positive effect on trabecular bone score in rheumatoid arthritis patients: 1-year follow-upZdenko Killinger, Lenka Gajdarova, Martin Kuzma, et al.
United European Gastroenterology Journal|June 12, 2014
Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: A Slovak case-control studyTibor Hlavaty, Jozef Toth, Tomas Koller, et al.
World Journal of Gastroenterology|June 28, 2017
Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational studyTomas Koller, Martina Galambosova, Simona Filakovska, et al.
European Journal of Gastroenterology & Hepatology|October 25, 2017
Decrease of trabecular bone score reflects severity of Crohn's disease: results of a case-control studyAnna Krajcovicova, Martin Kuzma, Tibor Hlavaty, et al.
Journal of Crohn'S & Colitis|September 2, 2014
Combination therapy with an immunomodulator and anti-TNFα agent improves bone mineral density in IBD patientsAnna Krajcovicova, Tibor Hlavaty, Zdenko Killinger, et al.
Scientific Reports|April 9, 2020
Seasonal changes of circulating 25-hydroxyvitamin D correlate with the lower gut microbiome composition in inflammatory bowel disease patientsKatarina Soltys, Martina Stuchlikova, Tibor Hlavaty, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Crohn'S & Colitis|June 6, 2015
Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much?Tibor Hlavaty, Anna Krajcovicova, Juraj Payer
European Journal of Gastroenterology & Hepatology|February 11, 2014
Delayed hypersensitivity reaction after initial dose of infliximab: a case reportAnna Krajcovicova, Tibor Hlavaty, Zuzana Zelinkova, et al.
World Journal of Gastroenterology|November 18, 2014
Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseasesTibor Hlavaty, Anna Krajcovicova, Tomas Koller, et al.
Acta Clinica Belgica|August 24, 2018
Biologic treatment in comparison to methotrexate has positive effect on trabecular bone score in rheumatoid arthritis patients: 1-year follow-upZdenko Killinger, Lenka Gajdarova, Martin Kuzma, et al.
United European Gastroenterology Journal|June 12, 2014
Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: A Slovak case-control studyTibor Hlavaty, Jozef Toth, Tomas Koller, et al.
World Journal of Gastroenterology|June 28, 2017
Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational studyTomas Koller, Martina Galambosova, Simona Filakovska, et al.
European Journal of Gastroenterology & Hepatology|October 25, 2017
Decrease of trabecular bone score reflects severity of Crohn's disease: results of a case-control studyAnna Krajcovicova, Martin Kuzma, Tibor Hlavaty, et al.
Journal of Crohn'S & Colitis|September 2, 2014
Combination therapy with an immunomodulator and anti-TNFα agent improves bone mineral density in IBD patientsAnna Krajcovicova, Tibor Hlavaty, Zdenko Killinger, et al.
Scientific Reports|April 9, 2020
Seasonal changes of circulating 25-hydroxyvitamin D correlate with the lower gut microbiome composition in inflammatory bowel disease patientsKatarina Soltys, Martina Stuchlikova, Tibor Hlavaty, et al.
Pageof 1